|
| ID |
DDInter280 |
| Drug Type |
small molecule |
| Molecular Formula |
C24H25Fo5S |
| Molecular Weight |
444.523
|
| Description |
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM.
|
| ATC Classification |
A10BD16
A10BK02
|
| IUPAC Name |
(2S,3R,4R,5S,6R)-2-(3-{[5-(4-Fluorophenyl)Thiophen-2-Yl]Methyl}-4-Methylphenyl)-6-(Hydroxymethyl)Oxane-3,4,5-Triol |
| InChI |
Inchi=1S/C24H25Fo5S/C1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/H2-10,19,21-24,26-29H,11-12H2,1H3/T19-,21-,22+,23-,24+/M1/S1 |
| InChI Key |
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N |
| Canonical SMILES |
[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|